TAVI in Complex Dual-Level Obstruction: A Case of Severe Aortic Stenosis and Subaortic Membrane
References
- Vahanian A, Beyersdorf F, Praz F, et al; ESC/EACTS Scientific Document Group, ESC National Cardiac Societies. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2022 Feb 12;43(7):561-632. doi: 10.1093/eurheartj/ehab395
- Finkelstein A, Keren G, Banai S. Treatment of severe valvular aortic stenosis and subvalvular discrete subaortic stenosis and septal hypertrophy with Percutaneous CoreValve Aortic Valve Implantation. Catheter Cardiovasc Interv. 2010 Apr 1;75(5):801-3. doi: 10.1002/ccd.22318
- TCTMD [Internet]. New York, NY: Cardiovascular Research Foundation; c2025. Alzubi J.
Miami Valves 2023 Presentation: Percutaneous treatment of a subaortic membrane using a self-expandable TAVR Valve ; 2023 Feb 2 [cited 2025 Apr 28]. Available from:https://www.tctmd.com/slide/percutaneous-treatment-subaortic-membrane-using-self-expandable-tavr-valve .
DOI: https://doi.org/10.14797/mdcvj.1539 | Journal eISSN: 1947-6108
Language: English
Page range: 53 - 56
Submitted on: Dec 22, 2024
Accepted on: Mar 11, 2025
Published on: May 12, 2025
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
Keywords:
© 2025 Salem Assiri, Mohammed S. Alshammakh, Sultan M. Alzahrani, Moath Said Alfawara, Khaled Al-Shaibi, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.